PL3911347T3 - Kompozycja do stosowania w leczeniu nietrzymania moczu u kobiet - Google Patents

Kompozycja do stosowania w leczeniu nietrzymania moczu u kobiet

Info

Publication number
PL3911347T3
PL3911347T3 PL20700172.8T PL20700172T PL3911347T3 PL 3911347 T3 PL3911347 T3 PL 3911347T3 PL 20700172 T PL20700172 T PL 20700172T PL 3911347 T3 PL3911347 T3 PL 3911347T3
Authority
PL
Poland
Prior art keywords
women
treatment
composition
urinary incontinence
incontinence
Prior art date
Application number
PL20700172.8T
Other languages
English (en)
Inventor
Sossio MORRA
Original Assignee
Axeen Pharma S.A.R.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axeen Pharma S.A.R.L. filed Critical Axeen Pharma S.A.R.L.
Publication of PL3911347T3 publication Critical patent/PL3911347T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/899Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13Coniferophyta (gymnosperms)
    • A61K36/15Pinaceae (Pine family), e.g. pine or cedar
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/42Cucurbitaceae (Cucumber family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL20700172.8T 2019-01-18 2020-01-13 Kompozycja do stosowania w leczeniu nietrzymania moczu u kobiet PL3911347T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1900478A FR3091819B1 (fr) 2019-01-18 2019-01-18 Composition pour le traitement et/ou la prevention des symptomes du bas appareil urinaire
PCT/EP2020/050671 WO2020148224A1 (fr) 2019-01-18 2020-01-13 Composition pour le traitement et/ou la prevention des symptomes du bas appareil urinaire

Publications (1)

Publication Number Publication Date
PL3911347T3 true PL3911347T3 (pl) 2024-02-05

Family

ID=66867402

Family Applications (1)

Application Number Title Priority Date Filing Date
PL20700172.8T PL3911347T3 (pl) 2019-01-18 2020-01-13 Kompozycja do stosowania w leczeniu nietrzymania moczu u kobiet

Country Status (13)

Country Link
US (1) US12109246B2 (pl)
EP (1) EP3911347B1 (pl)
JP (1) JP7494186B2 (pl)
CN (1) CN113316456B (pl)
AU (1) AU2020209886B2 (pl)
CA (1) CA3123859A1 (pl)
DK (1) DK3911347T3 (pl)
ES (1) ES2966149T3 (pl)
FR (1) FR3091819B1 (pl)
MX (1) MX2021008602A (pl)
PL (1) PL3911347T3 (pl)
PT (1) PT3911347T (pl)
WO (1) WO2020148224A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202000027423A1 (it) * 2020-11-16 2022-05-16 Kolinpharma S P A Composizione multicomponente e suo uso nel trattamento di patologie della prostata
PL4304667T3 (pl) 2021-03-16 2024-09-23 Aalto University Foundation Sr Kompozycja do stosowania w leczeniu nietrzymania moczu lub kału

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5690102B2 (ja) 2010-08-28 2015-03-25 アサマ化成株式会社 泌尿器系疾患予防治療用組成物及びその製造方法
FR3055215B1 (fr) 2016-08-31 2020-02-14 S.A.M. Serelys Pharma Composition comprenant des extraits de pollen et /ou de pistils
FR3068605B1 (fr) * 2017-07-10 2020-02-21 Serelys Pharma S.A.M. Composition pour le traitement et/ou la prevention des symptomes du bas appareil urinaire
FR3070263B1 (fr) * 2017-08-28 2020-07-24 Serelys Pharma S A M Composition pour son utilisation dans le traitement et/ou la prevention de l’infertilite

Also Published As

Publication number Publication date
EP3911347A1 (fr) 2021-11-24
JP7494186B2 (ja) 2024-06-03
DK3911347T3 (da) 2023-11-13
PT3911347T (pt) 2023-12-11
ES2966149T3 (es) 2024-04-18
FR3091819B1 (fr) 2021-04-23
CN113316456A (zh) 2021-08-27
AU2020209886A1 (en) 2021-08-26
EP3911347B1 (fr) 2023-10-04
US12109246B2 (en) 2024-10-08
FR3091819A1 (fr) 2020-07-24
US20230149498A1 (en) 2023-05-18
MX2021008602A (es) 2021-09-21
WO2020148224A1 (fr) 2020-07-23
CN113316456B (zh) 2024-05-14
BR112021013006A2 (pt) 2021-09-14
JP2022522997A (ja) 2022-04-21
AU2020209886B2 (en) 2025-01-23
CA3123859A1 (fr) 2020-07-23
BR112021013006A8 (pt) 2023-04-11

Similar Documents

Publication Publication Date Title
SI4010329T1 (sl) Devterirane spojine za uporabo pri zdravljenju raka
IL287464A (en) Anti-cd40 antibodies for use in the treatment of t1dm and insulitis
EP4066837A4 (en) USE OF BI853520 IN THE TREATMENT OF CANCER
GB2539858A (en) Vaginal insert
EP3744347A4 (en) COMPOSITION FOR USE IN THE TREATMENT OF SKIN DISEASES
SI4340842T1 (sl) Sotorasib za uporabo pri zdravljenju raka
PL3911347T3 (pl) Kompozycja do stosowania w leczeniu nietrzymania moczu u kobiet
ZA202107235B (en) Compositions and methods for treating ocular disease
PL3793497T3 (pl) Artykuł na inkontynencję w postaci pieluchomajtek
IL309172A (en) Vulbanazine for use in the additional treatment of schizophrenia
GB2595089B (en) Compositions for use in methods for preventing or treating incontinence, overactive bladder, or menstrual cramping
GB2591598B (en) Composition for the treatment of urinary tract infections
ZA202006886B (en) R-fadrozole for use in the treatment of aldostonerism
GB201918410D0 (en) Compounds and their use for the treatment of alpha1-antitrypsin deficiency
EP3781262A4 (en) COMPOSITIONS AND METHODS OF TREATING CARDIOVASCULAR DISEASE IN SELECTED PATIENTS
IL288307A (en) Preparations for use in the treatment of insulin deficiency conditions
PL4304667T3 (pl) Kompozycja do stosowania w leczeniu nietrzymania moczu lub kału
GB202002299D0 (en) Agents for use in the treatment of tissue damage
GB201908076D0 (en) Skin treatment composition
IL271180A (en) Methods for preventing and treating urinary incontinence
GB201918416D0 (en) Compounds and their use for the treatment of Alpha1-Antitrypsin deficiency
HK40074743A (en) Methylthioninium for use in the treatment of synaptopathies
GB202019103D0 (en) Device for the treatment of stress urinary incontinence
GB201918539D0 (en) Compounds for use in treatment and prophylaxis
GB202302121D0 (en) Compounds for use in the treatment of schizophrenia